JPWO2021046398A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021046398A5
JPWO2021046398A5 JP2022515099A JP2022515099A JPWO2021046398A5 JP WO2021046398 A5 JPWO2021046398 A5 JP WO2021046398A5 JP 2022515099 A JP2022515099 A JP 2022515099A JP 2022515099 A JP2022515099 A JP 2022515099A JP WO2021046398 A5 JPWO2021046398 A5 JP WO2021046398A5
Authority
JP
Japan
Prior art keywords
peptide
hrc
antiviral
fip
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022515099A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022551813A (ja
JP2022551813A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/049473 external-priority patent/WO2021046398A2/en
Publication of JP2022551813A publication Critical patent/JP2022551813A/ja
Publication of JP2022551813A5 publication Critical patent/JP2022551813A5/ja
Publication of JPWO2021046398A5 publication Critical patent/JPWO2021046398A5/ja
Pending legal-status Critical Current

Links

JP2022515099A 2019-09-04 2020-09-04 麻疹に対する併用抗ウイルス療法 Pending JP2022551813A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962895752P 2019-09-04 2019-09-04
US62/895,752 2019-09-04
US202062988286P 2020-03-11 2020-03-11
US62/988,286 2020-03-11
US202063009883P 2020-04-14 2020-04-14
US63/009,883 2020-04-14
PCT/US2020/049473 WO2021046398A2 (en) 2019-09-04 2020-09-04 Combination antiviral therapy for measles

Publications (3)

Publication Number Publication Date
JP2022551813A JP2022551813A (ja) 2022-12-14
JP2022551813A5 JP2022551813A5 (https=) 2023-09-13
JPWO2021046398A5 true JPWO2021046398A5 (https=) 2023-09-13

Family

ID=74853434

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022515099A Pending JP2022551813A (ja) 2019-09-04 2020-09-04 麻疹に対する併用抗ウイルス療法

Country Status (6)

Country Link
US (1) US20230014151A1 (https=)
EP (1) EP4025586A4 (https=)
JP (1) JP2022551813A (https=)
CN (1) CN114729007A (https=)
IL (1) IL291091A (https=)
WO (1) WO2021046398A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022159372A1 (en) * 2021-01-22 2022-07-28 Decoy Therapeutics, Inc. Methods and compositions for treating infections
WO2023150375A2 (en) * 2022-02-07 2023-08-10 Decoy Therapeutics Inc. Methods and compositions for treating covid infections
WO2025085916A1 (en) * 2023-10-20 2025-04-24 The Trustees Of Columbia University In The City Of New York Humanized monoclonal antibody and vaccines against measles virus
WO2025111546A1 (en) * 2023-11-22 2025-05-30 Board Of Trustees Of Michigan State University Development of broad-spectrum anti-opioid vaccines

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1692265T3 (da) * 2003-11-04 2011-11-21 Univ Tulane Fremgangsmåde til hindring af en virus-celle-fusion ved hæmning af fusionsinitieringsområdets funktion i RNA-vira med klasse 1-membranfusogene envelopeproteiner
CN101687911A (zh) * 2007-05-16 2010-03-31 康久化学生物技术公司 抗病毒肽的半胱磺酸衍生物
WO2012020108A2 (en) * 2010-08-11 2012-02-16 Cormus Srl Multimeric inhibitors of viral fusion and uses thereof
US10172961B2 (en) * 2014-05-07 2019-01-08 Cornell University Inhibitors of fusion between viral and cell membranes as well as compositions and methods of using them

Similar Documents

Publication Publication Date Title
JP5788178B2 (ja) ウィルス感染症の治療のための組成物及び方法
CN101415723B (zh) 具有改良生物学特性的hiv融合抑制肽
CN116059336A (zh) 针对rsv的疫苗
US20230086093A1 (en) Mutant rsv f protein and use thereof
CN107849558A (zh) 2型人副流感病毒载体和疫苗
US20230399364A1 (en) Immunogenic Coronavirus Fusion Proteins and Related Methods
EP4458844A1 (en) Anti-coronavirus polypeptide, and derivatives thereof and application thereof
JPWO2021046398A5 (https=)
US20030219451A1 (en) Stable helical C peptides and uses therefor
US20230140025A1 (en) Vectors for Producing Virus-Like Particles and Uses Thereof
US20070134221A1 (en) Stabilizing peptides
WO2024130061A1 (en) Immunogenic ebolavirus fusion proteins and related methods
WO2025167910A1 (zh) 一种可口服的长效多肽类hiv灭活剂
JPWO2021216891A5 (https=)
HK40098178A (zh) 人偏肺病毒疫苗
EP1500662A2 (en) Stabilizing peptides
HK40081120A (en) Mutant rsv f protein and use thereof